Real-time enrollment status for this plantar fibromatosis clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 2:15 AM UTC
| NCT Number | NCT06151197 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Plantar Fibromatosis |
| Phase | Clinical Trial |
| Target Enrollment | 418 participants |
| Active Locations | 63 sites in the US |
| Sponsor | Endo Pharmaceuticals |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of April 17, 2026: Clinical trial NCT06151197 is currently active_not_recruiting participants. This clinical trial study for plantar fibromatosis is not currently accepting new participants at 63 locations across the United States. The study is sponsored by Endo Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06151197 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06151197 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.